Quantum BioPharma is trading at $3.42, down 5.00%, with no clear company-specific catalyst identified for October 1, 2026.
- Available coverage showed no October 1 announcement and did not explain the decline.
- A September 30 podcast announcement featuring Executive Co-Chair Anthony Durkacz was reported, but no connection to the share-price move was established.
- Major indices in the supplied market context were only slightly changed. Shares had also closed lower on September 30 at $3.60 (-5.76%).